- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Dishman Pharmaceuticals & Chemicals IPO
₹541.25
+209.29% on listing
Listing-day close · 22 Apr 2004 · issue price ₹175
Dishman Pharmaceuticals & Chemicals’ ₹60.09 crore IPO was priced at ₹175 a share. It listed on 22 Apr 2004 and closed its first day at ₹541.25, up 209.29% on the issue price.
Timeline
- Opens
- Closes
- Listing
Issue details
- Issue size
- ₹60.09 Cr
- Fresh issue
- ₹60.09 Cr
- Offer for sale
- —
- Lot size
- 50 shares
- Minimum investment
- ₹8,750
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 38.41× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹240 Cr
- P/E (post-issue)
- 21.6
- EPS (post-issue)
- ₹8.10
- Price to book
- 3.5
- Promoter holding
- 99.99% → 74.99%
Financials as of 30 Sep 2003, from the offer documents.
Listing
- Listing date
- 22 Apr 2004
- Issue price
- ₹175
- Open
- —
- High
- —
- Low
- —
- Close
- ₹541.25
Listing day. The close was +209.29% on the issue price.
FAQs
When did the Dishman Pharmaceuticals & Chemicals IPO open and close?
It opened on 29 Mar 2004 and closed on 7 Apr 2004.
What was the Dishman Pharmaceuticals & Chemicals IPO price?
The price band was ₹155–175 a share. The final issue price was ₹175.
What is the lot size and minimum investment?
One lot is 50 shares, ₹8,750 at ₹175 a share. Retail investors apply in whole lots.
How much did Dishman Pharmaceuticals & Chemicals raise?
₹60.09 crore: ₹60.09 crore of new shares.
How many times was the Dishman Pharmaceuticals & Chemicals IPO subscribed?
38.41 times overall.
How did Dishman Pharmaceuticals & Chemicals list?
It listed on 22 Apr 2004 and closed the day at ₹541.25, up 209.29% on the ₹175 issue price.
Who is the registrar of the Dishman Pharmaceuticals & Chemicals IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app